Take on Next-Gen Biotechnology
Tech dilligence and strategy
Independent analysis
Most entities have a vested interest in the outcome of a strategy project or diligence process. Nonprofits promote a cause, and companies put their best foot forward. This makes sense but doesn’t show the whole picture. At Helikon, our only job is to give you the whole picture.
As independent evaluators, we believe science comes first, so we don’t take carry or equity for any diligence work. As independent, third-party evaluators, we are omnivores, vegetarians, vegans, meat lovers, bodybuilders, bakers, brewers, a family of ranchers, and foodies, but what unites us is a love of technology and a job well done.
Built for data-driven decision making
-
Tech due diligence is key for any major investment, and for a technology-driven company it is often as important as legal considerations.
Our diligence offerings focus first on core technologies. Competitor analysis and economic evaluation can be added to give a full picture and context for a company’s technology.
Projects range from seven days to two months depending on depth, complexity, and requirements, and can include site visits as requested.
-
Environmental, Social and Governance reporting is becoming more and more crucial as investors begin to quantify sustainability. Helikon works closely with investors and companies to provide targeted ESG reporting across many tech disciplines (precision fermentation, cell-based meat, alternative proteins, molecular farming, carbon capture, and more).
-
Sometimes deep tech goes deep enough to warrant a general technology evaluation. We provide deep analytical expertise to evaluate proof of concept technology.
-
Ongoing technical evaluation is key to managing a thriving innovation portfolio. We review incoming tech decks and companies as well as benchmark existing portfolio companies and outline success metrics.
-
Having a firm technical grounding is key when it comes to entering a new area. Helikon provides seminars, workshops, fireside chats, and roundtables that bring bleeding-edge tech discussions to the right context.
“[Helikon] is extremely knowledgeable in all things related to synthetic biology and terrific at … providing technical expertise and communicating hardcore scientific topics.”
- Nieves Martinez Marshall, Ph.D., Novel Farms Founder and CEO
LATEST HELIKON NEWS
•
LATEST HELIKON NEWS •
STAY UP TO DATE
At Helikon, we are serious about delivering high-quality reports and articles.
Ask the tough questions and get answers.
We bring scientists from across disciplines to work together on some of the most challenging advisory and diligence work at the frontiers of biotech to answer the most complex biotech questions.
Our team brings deep scientific expertise across the entire range of synthetic biology, from CRISPR to metabolic engineering to protein synthesis. Our experience crosses from cutting-edge research in proteomics and transcriptomics, to advanced machine learning and computational modeling, to real-world applications like liposome encapsulation, protein production and expression, biophysical assays, and microfluidics.
We have evaluated over 41 companies in the past three years from seed to scale.
Our Team
Insights
Reputation